Impact of Donor Type and Melphalan Dose on Allogeneic Transplant Outcomes for Patients with Lymphoma
暂无分享，去创建一个
S. Parmar | Y. Nieto | U. Popat | Q. Bashir | M. Qazilbash | L. Fayad | J. Westin | F. Hagemeister | P. Anderlini | R. Mehta | C. Hosing | P. Kebriaei | I. Khouri | N. Fowler | A. Olson | S. Srour | R. Saliba | Ciurea | Shpall | R. Champlin | Alousi | O. Stefan | G. Rondon | Oran Betul | Hun Lee | Farzaneh Maadani | Neeraj Y Saini | Amin | J. Elizabeth